DiMe’s sDHT Adoption Navigator helps clinical teams move from guidance to action, but the real test is whether organizations use it early enough to matter.
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
- Sites Are Building Their Own Tech – SCRS On What That Means
- Human-In-The-Loop In AI Validation And Control: From Principle To Practice
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
- HTA, Digital Twins, And Building Clinical Tech That Lasts
- Real-World Evidence And Wearables Are Reshaping Trial Tech
- Navigating Elsa's AI Transition: Practical Guidance To Safeguard Confidential Information (Part 3)
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
It's Official: CRIO Sites Are Now 25% Of US Sites On Chronic Condition Studies
CRIO continues to lead the U.S. eSource market, with its platform widely adopted across clinical research sites. A recent analysis of 50 Phase 2 and 3 studies showed that, on average, 28% of U.S. sites were CRIO clients, with even higher adoption in key therapeutic areas.
-
The Strategic Case For RTSM in Phase 1 Trials
Phase 1 trials demand precision and speed. RTSM delivers real-time control over enrollment, dosing, and supply, reducing risk and enabling adaptive strategies that keep timelines on track.
-
Why Prospective Real-World Studies Hold Promise For Research
Clinical research has always been a cautious and time-consuming affair. Discover how prospective real-world studies are poised to transform the role of RWE in clinical research.
-
Kicking Off A Clinical Trial The Right Way - With Seamless Digital Consent
Read this blog to learn more about how eConsent can enhance participant engagement and retention when used both onsite and remotely.
-
The Strategic Role Of KOLs In Rare Disease Drug Development
Engaging key Opinion Leaders (KOL) is crucial for accelerating rare disease research breakthroughs. However, identifying the right experts is challenging due to fragmented data and evolving expertise.
-
Trends Shaping The Pharmaceutical Industry's Future
Decentralized trials and patient choice are key to expanding study reach. Here, we examine how patient access increases with diverse options and AI-powered connections across health systems and sites.
-
How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers
Explore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
-
Revolutionizing Pediatric Clinical Trials With ePRO And eConsent
Digital tools like ePRO and eConsent are essential in addressing pediatric trial challenges such as the diverse participant ages and family involvement, which impact retention and data quality.
-
Achieving Clinical Operations Excellence
Learn how Revvity Signals Software clinical solutions give clinical operations organizations the unprecedented ability to reduce the time, cost and risk of running clinical trials while accelerating the time to market for products across the entire portfolio of clinical candidates.
-
Five Steps To Streamline Your Trial
Explore the solution for adequately verifying and analyzing data from wearables, remote devices, and other novel data collection modalities.
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- Sites Are Building Their Own Tech – SCRS On What That Means
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
RECENT NEWSLETTERS
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
- 04.30.26 -- AI, RWE & Predictive Analytics Are Reshaping Trials
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More